propiconazole has been researched along with Ganglioglioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gawish, I; Hopf, N; Kockro, R; Reisch, R; Schwandt, E; Stadie, A | 1 |
Hinton, DR; Sadun, AA; Sadun, F | 1 |
1 review(s) available for propiconazole and Ganglioglioma
Article | Year |
---|---|
Rapid growth of an optic nerve ganglioglioma in a patient with neurofibromatosis 1.
Topics: Adolescent; Antigens, Neoplasm; Cranial Nerve Neoplasms; Female; Ganglioglioma; Glial Fibrillary Acidic Protein; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Magnetic Resonance Imaging; Neoplasm Proteins; Neurofibromatosis 1; Nuclear Proteins; Optic Nerve Diseases; Orbit; Phosphopyruvate Hydratase; Synaptophysin | 1996 |
1 other study(ies) available for propiconazole and Ganglioglioma
Article | Year |
---|---|
The minimally invasive supraorbital subfrontal key-hole approach for surgical treatment of temporomesial lesions of the dominant hemisphere.
Topics: Adult; Astrocytoma; Brain Neoplasms; Craniotomy; Dominance, Cerebral; Female; Frontal Bone; Frontal Lobe; Ganglioglioma; Hemangioma, Cavernous, Central Nervous System; Hippocampus; Humans; Male; Middle Aged; Minimally Invasive Surgical Procedures; Neurosurgical Procedures; Orbit; Parahippocampal Gyrus; Postoperative Complications; Preoperative Care; Temporal Lobe; Treatment Outcome; Young Adult | 2009 |